Eyebright Medical(688050.SH)

Last Updated 00:00:00
longbridge loading

Eyebright Medical has established its Asia-Pacific headquarters in Singapore, with the regional market becoming increasingly important for the group's growth | Lianhe Zaobao

Zaobao·
SZ
159898
-1.34%
SH
688050
-2.74%
SH
562600
-1.21%
Zaobao·
SZ
159898
-1.34%
SH
688050
-2.74%
SH
562600
-1.21%

30 public funds participated in the fixed increase, and 23 achieved full floating profits on the projects

Zhitong·
SH
688050
-2.74%
SH
605300
-0.75%
Zhitong·
SH
688050
-2.74%
SH
605300
-0.75%

Eyebright Medical: The Focus Deep Extended Artificial Lens has been approved for market launch through the Innovative Medical Device Special Review Procedure

Zhitong·
SH
688050
-2.74%
Zhitong·
SH
688050
-2.74%

Eyebright Medical: The company has not yet applied the materials of its main business products in the field of robotics

Zhitong·
SH
688050
-2.74%
Zhitong·
SH
688050
-2.74%

Eyebright Medical: Shareholder reduced holdings by 1.9972%

Zhitong·
SH
688050
-2.74%
Zhitong·
SH
688050
-2.74%

Ophthalmology medical concept stocks surged, SPAS hit the daily limit in the afternoon

Zhitong·
SZ
003020
-1.58%
SZ
301096
+0.21%
SH
688050
-2.74%
Zhitong·
SZ
003020
-1.58%
SZ
301096
+0.21%
SH
688050
-2.74%

Eyebright Medical: Net profit of 213 million yuan in the first half of 2025, a year-on-year increase of 2.53%

Zhitong·
SH
688050
-2.74%
Zhitong·
SH
688050
-2.74%

Goldman Sachs focuses on "wealthy elderly individuals," brain-computer interfaces, and gene drugs are the future of high-end self-paid medical care in China

Wallstreetcn·
SZ
300122
-1.27%
SH
688050
-2.74%
SZ
300142
-1.20%
Wallstreetcn·
SZ
300122
-1.27%
SH
688050
-2.74%
SZ
300142
-1.20%

Global Growth Companies With High Insider Ownership July 2025

Simplywall·
SH
688050
-2.74%
HK
09863
+2.61%
Simplywall·
SH
688050
-2.74%
HK
09863
+2.61%

3 Global Stocks Estimated To Be Undervalued By Up To 29.9%

Simplywall·
US
NYAX
-0.28%
SH
688050
-2.74%
6323
0.00%
Simplywall·
US
NYAX
-0.28%
SH
688050
-2.74%
6323
0.00%
© 2026 Longbridge｜Disclaimer